Vedolizumab use and the associations between α4β7 expression and HIV reservoir in the gut during treated primary HIV infection
File(s)AIDS-D-19-00507.pdf (1.06 MB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Latent HIV infection in gut CD4+ cells is a barrier to HIV eradication. α4β7 integrin is a gut homing marker expressed on CD4+ cells. Monoclonal antibodies against α4β are being trialled to induce HIV remission. Using gut biopsy samples taken from a cohort of HIV+ individuals treated during primary HIV infection, we characterised β7 expression and HIV DNA in terminal ileum and rectum. We demonstrate an association between HIV DNA and β7 expression in gut, and present the case of a HIV+ individual treated with an α4β7 antibody; finding no evidence of HIV remission by humanized murine viral outgrowth assay.
Date Issued
2019-11-15
Date Acceptance
2019-06-27
Citation
AIDS, 2019, 33 (14), pp.2268-2271
ISSN
0269-9370
Publisher
Lippincott, Williams & Wilkins
Start Page
2268
End Page
2271
Journal / Book Title
AIDS
Volume
33
Issue
14
Copyright Statement
This paper is embargoed until 12 months after publication.
Sponsor
Medical Research Council (MRC)
Medical Research Council
Imperial College Healthcare NHS Trust- BRC Funding
Medical Research Council (MRC)
Imperial College Healthcare NHS Trust- BRC Funding
Grant Number
MR/N001265/1
MR/N001265/1
RDA02 79560
n/a
RDA02
Subjects
06 Biological Sciences
11 Medical and Health Sciences
17 Psychology and Cognitive Sciences
Virology
Publication Status
Published